Company news
Jianmin Pharmaceutical Group Co Ltd. news in 2025
Jianmin Pharmaceutical Group Co Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on the Approval of Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution for Marketing
December 10, 2025
Announcement on Implementation of Providing Guarantee for Subsidiary's Bank Credit Line
November 26, 2025
Announcement on Obtaining Notice of Approval for Drug Clinical Trial
October 27, 2025
Report for Q3 2025
October 21, 2025
Announcement on Convening the Performance Briefing in Q3 2025
October 14, 2025
Announcement on the Approval of Furosemide Oral Solution for Marketing
September 1, 2025
Announcement on Resolutions of the 2nd Meeting of the 11th Board of Directors
August 19, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
August 12, 2025
Announcement on Resolutions of the 1st Meeting of the 11th Board of Directors
July 30, 2025
Announcement on Engaging in Asset Pool Business
July 14, 2025
Announcement on the Waiver of the Preemptive Right to Acquire Equity Interests in an Associated Enterprise and Other Related Matters
July 4, 2025
Announcement on Attending the 2025 Online Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction
June 9, 2025
Announcement on Resignation of Senior Management Member
May 9, 2025
Announcement on Implementation of Dividend Distribution for 2024
April 23, 2025
Announcement on the Approval of Pediatric Bezoar Antipyretic Plaster for Marketing
April 21, 2025
Announcement on Resolution of the 34th Meeting of the 10th Board of Directors
April 18, 2025
Announcement on Resolution of the 2024 Annual General Meeting
April 15, 2025
Announcement on Resolutions of the 16th Meeting of the 10th Board of Supervisors
March 21, 2025
Announcement on Convening 2024 Annual Performance Briefing
March 17, 2025
Implementation Announcement on Providing Guarantee for Bank Credit Lines of Subsidiary
January 22, 2025
Announcement on External Donations
January 13, 2025